We unpacked the controversies and possible market-based solutions generated by the new FDA-approved drug to treat patients with Alzheimer's Disease on today's episode of the 4sight Friday Roundup podcast.
Here the week's biggest news around market-based change.
<ul>
 <li>David Johnson is CEO of 4sight Health.</li>
 <li>Julie Vaughan Murchinson is Partner of Transformation Capital and former CEO of Health Evolution.</li>
 <li>David Burda is News Editor and Columnist of 4sight Health.</li>
</ul>
Subscribe&nbsp;on&nbsp;<a href="https://podcasts.apple.com/us/podcast/id1530045455" rel="noopener noreferrer" target="_blank">iTunes</a>,&nbsp;<a href="https://open.spotify.com/show/0yAzDcHPHyRqxv3U1WA9Bd" rel="noopener noreferrer" target="_blank">Spotify</a>,&nbsp;<a href="https://anchor.fm/4sight-health" rel="noopener noreferrer" target="_blank">other services</a>.
Click play to listen to the 6/11/2021 Episode.

Physician Supply, Demand and Competition

Your best 20 minutes this week, where outcomes matter, customers count and value rules. Hear analysis of the crucial market-based healthcare news and speculation for the week ahead. The customer revolution in healthcare comes alive in this must-listen podcast for forward-thinking healthcare executives.

David Burda, 4sight Health’s news editor, hosts with commentary from David Johnson, 4sight Health’s CEO, and Julie Murchinson, Partner at Transformation Capital. Join the Customer Revolution!

Subscribe through your streaming service.

Read more at https://www.4sighthealth.com/insights/